Bavarian, mpox vaccine
EU drug regulator approves Bavarian's mpox vaccine for adolescents, company says
The EU's drug regulator has approved Bavarian Nordic's mpox vaccine for use in adolescents aged 12 to 17 years, the company said on Thursday, bolstering evidence for using the shot in that age group to contain an outbreak in parts of Africa.
Bavarian Gets EU Approval for Mpox Vaccine for Adolescents
Bavarian Nordic A/S, one of the only companies with a vaccine approved for mpox, has received regulatory approval in Europe for the use of its jab for adolescents.
Gavi to obtain 500,000 mpox vaccine doses from Bavarian Nordic
Gavi (the Global Alliance for Vaccines and Immunization) has entered an advance purchase agreement with Bavarian Nordic to secure 500,000 doses of the modified vaccinia Ankara-Bavarian Nordic (MVA-BN) mpox vaccine. The vaccines, marketed under names including JYNNEOS and IMVANEX, are intended for supply in African countries.
Bavarian says mpox vaccine approved by EU regulator for adolescents
LONDON (Reuters) -Bavarian Nordic said on Thursday its mpox vaccine was approved by the EU's drug regulator for use in adolescents, bolstering the case for using the shot in the 12 to 17 age group to contain an outbreak in parts of Africa.
EU Approves Use of Bavarian Nordic's Mpox Vaccine for Adolescents
Bavarian Nordic's mpox vaccine has gained approval for use in adolescents by the EU's drug regulator. This move is seen as essential for containing an outbreak in parts of Africa, with the World Health Organization declaring mpox a global public health emergency.
EU drugs watchdog backs Bavarian Nordic’s mpox vaccine for adolescents
The European Commission has greenlit Bavarian Nordic’s mpox and smallpox vaccine for approval for kids aged 12 to 17. The European Medicines Agency carried out an expedited and positive review of the data in this patient group, the company said, with the Commission accepting the regulator's opinion.
UK government buys over 150,000 doses of Bavarian Nordic's mpox vaccine
The UK government has ordered more than 150,000 doses of Bavarian Nordic's mpox vaccine to boost its preparedness against a new form of the virus currently spreading in African countries.
Bavarian Nordic Gets EMA Approval Of Mpox Vaccine For Adolescents
(RTTNews) - Bavarian Nordic A/S (BAVA) Thursday said that the European Commission has adopted the Committee for Medicinal Products for Human Use (CHMP) recommendation for the approval of a type II variation for IMVANEX smallpox and mpox vaccine. This extends the current marketing authorization to include adolescents 12 to 17 years of age.
FiercePharma10h
Gavi, UK government tap Bavarian Nordic for 650,000 doses of mpox vaccine
Gavi, the Vaccine Alliance and the U.K. government ordered a combined 650,000 doses of Bavarian Nordic’s Jynneos mpox vaccine ...
Bavarian Gets Order for Half a Million Mpox Shots for Africa
Gavi, the Vaccine Alliance, is purchasing 500,000 mpox vaccines from Bavarian Nordic A/S for African countries hardest-hit by ...
WHO clears Bavarian Nordic's vaccine for mpox, sets up access scheme
The World Health Organization and partners on Friday set up a scheme to help bring mpox vaccines, tests and treatments to the ...
Euroinvestor23h
Bavarian Nordic Receives EMA Approval of Mpox Vaccine for Adolescents
MVA-BN approved for use against mpox and smallpox in adolescents 12-17 years of age after expedited review with EMARepresents the second EMA approval of an MVA-BN-based vaccine for a younger ...